Wang, Lan
Guan, Xin
Wang, Huihui
Shen, Bin
Zhang, Yu
Ren, Zhihua
Ma, Yupo
Ding, Xinxin
Jiang, Yongping
Funding for this research was provided by:
The State Scientific Key Projects for New Drug Research and Development of China (2014ZX09101042-004)
International Cooperation Program of China (2013DFA30830)
Article History
Received: 30 March 2017
Revised: 27 June 2017
Accepted: 29 June 2017
First Online: 18 July 2017
Change Date: 17 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13287-021-02535-y
Ethics approval and consent to participate
: The mobilized human peripheral blood was provided from West China Hospital, Sichuan University (Chengdu, Sichuan, China). Fresh umbilical cord blood samples (used within 6–8 h of birth) from anonymous donors were provided by the Soochow Municipal Hospital (Suzhou, Jiangsu, China). All the blood samples were acquired after volunteers’ written informed consent. The study protocol was approved by the Hospital's Ethics Committee and Research Ethics Advisory Committee (Permit Number 2015SZSLK075). Experimental protocols for mice were approved by the Institutional Animal Care and Use Committees of Soochow University and the Experimental Animal Ethics Committee of the Institute (IACUC permit number: SYXK (Su) 2012-0045).
: Not applicable.
: HW and ZR are employees of Biopharmagen Corp. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.